Comp drug Lyrica approved for generic production

The U.S. Food and Drug Administration on Monday  announced its approval of the first generic versions of Lyrica, a drug called “pregabalin” that falls into the category of anticonvulsant, epilepsy drugs often used off-label to treat pain — now a top class of drugs in workers compensation.

Lyrica became eligible for generic applications in June, according to experts, and nine applications have been approved for generics, the FDA announced. It is still touted as an anticonvulsant, a class of drugs that can calm nerve reactions.

Cited in comp circles as a more-expensive alternative to opioids, the FDA said in its statement that Lyrica can be used for managing “neuropathic pain associated with spinal cord injury.”